Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Lyerly

Showing results (81-90 of 218) with videos related to

Pageof 22
Sort By:
Psycho-Oncology|September 30, 2010
Correlates of quality of life-related outcomes in breast cancer patients participating in the Pathfinders pilot studySophia K Smith, James E Herndon, H Kim Lyerly, et al.
Cancer Research|September 9, 2010
Ligand-independent toll-like receptor signals generated by ectopic overexpression of MyD88 generate local and systemic antitumor immunityZachary C Hartman, Takuya Osada, Oliver Glass, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2010
Identification of select glucocorticoids as Smoothened agonists: potential utility for regenerative medicineJiangbo Wang, Jiuyi Lu, Michael C Bond, et al.
Biochemistry|September 24, 2009
The anti-helminthic niclosamide inhibits Wnt/Frizzled1 signalingMinyong Chen, Jiangbo Wang, Jiuyi Lu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 23, 2004
Enumerating antigen-specific T-cell responses in peripheral blood: a comparison of peptide MHC Tetramer, ELISpot, and intracellular cytokine analysisAmy C Hobeika, Michael A Morse, Takuya Osada, et al.
Nuclear Medicine and Biology|August 27, 2014
N-Succinimidyl guanidinomethyl iodobenzoate protein radiohalogenation agents: influence of isomeric substitution on radiolabeling and target cell residualizationJaeyeon Choi, Ganesan Vaidyanathan, Eftychia Koumarianou, et al.
Cancer Immunology, Immunotherapy : CII|August 4, 2017
An unbiased in vivo functional genomics screening approach in mice identifies novel tumor cell-based regulators of immune rejectionCasey W Shuptrine, Reham Ajina, Elana J Fertig, et al.
Bioorganic & Medicinal Chemistry|August 15, 2015
Structure-activity studies of Wnt/β-catenin inhibition in the Niclosamide chemotype: Identification of derivatives with improved drug exposureRobert A Mook, Jiangbo Wang, Xiu-Rong Ren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2020
Novel Therapeutic Interventions Early in the Disease Trajectory: Drug Development Beyond the Refractory SettingNavid Hafez, Hope S Rugo, Margaret A Tempero, et al.
Journal of Pain and Symptom Management|April 28, 2009
Feasibility and acceptability to patients of a longitudinal system for evaluating cancer-related symptoms and quality of life: pilot study of an e/Tablet data-collection system in academic oncologyAmy P Abernethy, James E Herndon, Jane L Wheeler, et al.
Pageof 22

Showing results (81-90 of 218) with videos related to

Sort By:
Pageof 22
Psycho-Oncology|September 30, 2010
Correlates of quality of life-related outcomes in breast cancer patients participating in the Pathfinders pilot studySophia K Smith, James E Herndon, H Kim Lyerly, et al.
Cancer Research|September 9, 2010
Ligand-independent toll-like receptor signals generated by ectopic overexpression of MyD88 generate local and systemic antitumor immunityZachary C Hartman, Takuya Osada, Oliver Glass, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2010
Identification of select glucocorticoids as Smoothened agonists: potential utility for regenerative medicineJiangbo Wang, Jiuyi Lu, Michael C Bond, et al.
Biochemistry|September 24, 2009
The anti-helminthic niclosamide inhibits Wnt/Frizzled1 signalingMinyong Chen, Jiangbo Wang, Jiuyi Lu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 23, 2004
Enumerating antigen-specific T-cell responses in peripheral blood: a comparison of peptide MHC Tetramer, ELISpot, and intracellular cytokine analysisAmy C Hobeika, Michael A Morse, Takuya Osada, et al.
Nuclear Medicine and Biology|August 27, 2014
N-Succinimidyl guanidinomethyl iodobenzoate protein radiohalogenation agents: influence of isomeric substitution on radiolabeling and target cell residualizationJaeyeon Choi, Ganesan Vaidyanathan, Eftychia Koumarianou, et al.
Cancer Immunology, Immunotherapy : CII|August 4, 2017
An unbiased in vivo functional genomics screening approach in mice identifies novel tumor cell-based regulators of immune rejectionCasey W Shuptrine, Reham Ajina, Elana J Fertig, et al.
Bioorganic & Medicinal Chemistry|August 15, 2015
Structure-activity studies of Wnt/β-catenin inhibition in the Niclosamide chemotype: Identification of derivatives with improved drug exposureRobert A Mook, Jiangbo Wang, Xiu-Rong Ren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2020
Novel Therapeutic Interventions Early in the Disease Trajectory: Drug Development Beyond the Refractory SettingNavid Hafez, Hope S Rugo, Margaret A Tempero, et al.
Journal of Pain and Symptom Management|April 28, 2009
Feasibility and acceptability to patients of a longitudinal system for evaluating cancer-related symptoms and quality of life: pilot study of an e/Tablet data-collection system in academic oncologyAmy P Abernethy, James E Herndon, Jane L Wheeler, et al.
Pageof 22